REG-Canaccord Gen Grp: Strengthens Global Healthcare and Technology Capability <Origin Href="QuoteRef">CF.TO</Origin>

Canaccord GenuityAnnouncement

28/05/2015 15:20

CANACCORD GENUITY STRENGTHENS GLOBAL HEALTHCARE AND TECHNOLOGY CAPABILITY WITH 
         ADDITION OF KEY INVESTMENT BANKING AND RESEARCH PROFESSIONALS         

TORONTO, May 28, 2015 - Canaccord Genuity (the "Company") is pleased to
announce the expansion of its Healthcare and Technology practices with the
addition of three senior capital markets professionals. Based in Nashville, the
group will focus on the fast growing sectors of Healthcare Information
Technology ("HCIT") and Outsourced Healthcare Services.

"Nashville has become a centre of innovation for the global healthcare industry
and is home to a diverse collection of dynamic growth companies," commented Dan
Daviau, CEO, North American Capital Markets, Canaccord Genuity. "These
appointments underscore our commitment to advancing our coverage of relevant
growth sectors and delivering best in class equity research, investment banking
and advisory expertise across our global platform."

Dudley Baker joins as Managing Director, Investment Banking and brings over 13
years of investment banking, private equity, and corporate development
experience to his role. Most recently, he served as Managing Director at
Avondale Partners, LLC, where he led coverage of HCIT and Business Services.
Previously, he worked at Morgan Joseph Inc. where he focused on healthcare and
business services transactions. Dudley holds an MBA from the Owen Graduate
School of Management at Vanderbilt University and a B.A. from Rhodes College.

Roger Briggs joins as Managing Director, Investment Banking and brings more
than three decades of experience to the team.  In addition to supporting the
Healthcare investment banking practice, Roger will focus his efforts on
building the US financial sponsors coverage. Most recently, Roger was an
Operating Partner at Trilantic Capital Partners, a global private equity firm.
Previously, he was a Founder and former Head of Investment Banking at Morgan
Joseph, Inc.; Head of Investment Banking at SunTrust Equitable Securities; Head
of Mergers and Acquisitions at Bankers Trust and a founding member of the
Mergers and Acquisitions group at Solomon Brothers.  Roger holds a B.S. from
Northwestern University.

Richard Close joins the equity research division as a Managing Director and
will lead coverage of the HCIT, Supply Chain and Outsourced Healthcare Services
sectors. Most recently, Richard was Managing Director and Senior Research
Analyst at Avondale Partners, LLC. Prior to this, he worked at Jefferies in a
similar capacity for seven years and as an equity research analyst at SunTrust
Robinson Humphrey and its predecessor companies for six years. Richard holds a
B.S. in Economics from the Rochester Institute of Technology.

Canaccord Genuity's Healthcare & Life Sciences equity research coverage
universe is led by 10 research analysts located across three continents
providing award-winning global coverage and investment ideas for the
Biotechnology, Specialty Pharmaceuticals, Medical Devices, Life Sciences Tools,
HCIT and Outsourced Healthcare Services subsectors.

ABOUT CANACCORD GENUITY GROUP INC.:

Through its principal subsidiaries, Canaccord Genuity Group Inc. (the
"Company") is a leading independent, full-service financial services firm, with
operations in two principal segments of the securities industry: wealth
management and capital markets.  Since its establishment in 1950, the Company
has been driven by an unwavering commitment to building lasting client
relationships. We achieve this by generating value for our individual,
institutional and corporate clients through comprehensive investment solutions,
brokerage services and investment banking services.  The Company has offices in
10 countries worldwide, including Wealth Management offices located in Canada,
Australia, the UK and Europe.  Canaccord Genuity, the international capital
markets division, operates in Canada, the US, the UK, France, Ireland, Hong
Kong, China, Singapore, Australia and Barbados.  To us there are no foreign
markets.TM

Canaccord Genuity Group Inc. is publicly traded under the symbol CF on the TSX
and the symbol CF. on the London Stock Exchange. 

FOR FURTHER INFORMATION CONTACT:

North America media: 
Scott Davidson
Executive Vice President, Global Head of Corporate Development and Strategy
Phone: 416-869-3875, email: scott.davidson@canaccord.com

For investor relations inquiries contact:
Christina Marinoff
Vice President, Investor Relations & Communications
Phone: 416-687-5507, email: christina.marinoff@canaccord.com

London media:
Robert Morgan
Stockwell
Phone: +44 (0) 20 7240 2486, email: robert.morgan@stockwellgroup.com

Brokers:
Oliver Hearsey
RBC Europe Limited
Phone: +44 (0) 20 7653 4000, email: oliver.hearsey@rbccm.com

Simon Hardy or Alex Collins
Jefferies International Limited
Phone: +44 (0) 20 7029 8000, email: simon.hardy@jefferies.com;
alex.collins@jefferies.com



END



Copyright © 2015 PR Newswire Association, LLC. All Rights Reserved